Updates are available Correction dated 2023-09-27
Click to view Correction: https://doi.org/10.1007/s40258-023-00828-2
Updates are available Correction dated 2022-03-18
Click to view Correction: https://doi.org/10.1007/s40258-022-00724-1
-
Authors
Thom, Howard http://orcid.org/0000-0001-8576-5552
-
Funding
Funding for this research was provided by:
UK Medical Research Council (MR/S036709/1)
- License Information
-
More Information
Article History
Accepted: 7 November 2021
First Online: 20 January 2022
Change Date: 18 March 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40258-022-00724-1
Change Date: 27 September 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40258-023-00828-2
Declarations
:
: This work was funded by the UK Medical Research Council grant MR/S036709/1.
: I have received consulting fees from Novartis Pharma AG, Pfizer Inc, Roche Holding AG, Eisai Inc, Argenx, Janssen Pharmaceutical and BMS. None is directly related to this work.
: All data and code used in this paper are provided in the supplementary material.
: This work emerged from an issue panel I chaired for the International Society for Pharmcoeconomics and Outcomes Research (ISPOR) European congress in 2020. It was entitled “Uncertainty and Healthcare Decision Making: A Dangerous Combination?” I would like to thank my panellists Jeroen Jansen of University of California in USA, Stephane Regnier of Lundbeck in Switzerland, and Sabine Grimm of Masstricht University Medical Centre in Belgium. I give huge thanks to Dr Sanchez Alvarez at Hoffmann-La Roche who identified an error in the R code; this was corrected in a correction.
: Not applicable.
: Not applicable.
: Not applicable.
